Literature Review: Diagnosis, Classification, Clinical Manifestations, Pathophysiology, and Treatment of Diabetic Neuropathy
DOI:
10.29303/jossed.v6i2.12785Published:
2025-10-31Downloads
Abstract
Diabetic neuropathy (DN) is a very common and debilitating complication of Diabetes Mellitus disease that greatly affects quality of life. The literature review aims to critically summarize recent findings that examine the development of understanding of DN, from a simple complication to a complex and multifaceted disease. This study used a literature review based on articles obtained from Google Scholar and PubMed databases. All articles discussed Diabetic Neuropathy from the perspective of pathophysiology, clinical classification, diagnosis, and management. The analysis was conducted using a descriptive-qualitative approach, reported pharmacological and non-pharmacological therapy options. Based on the search, all articles that met the inclusion criteria were narrative reviews, consensus studies, and case reports. These articles outlined the complexities of Diabetic Neuropathy diagnosis, evolving pathophysiological theories, and therapeutic approaches. A multidisciplinary diagnostic approach that includes a thorough history, neurological clinical examination, and ancillary tests (e.g., HbA1c, MRI) is essential. Management involves pharmacological therapy (e.g., tricyclic antidepressants, gabapentinoid), non-pharmacological therapy (e.g., cognitive behavioral therapy, nerve blocks), and comprehensive oral health management. Interdisciplinary collaboration between clinicians, neurologists, and endocrinologists is essential for optimal patient care. Further research is needed to understand the detailed mechanisms and develop more effective therapies
Keywords:
Diabetes Mellitus, Neuropathy, Painful Diabetic NeuropathyReferences
Alare, K., Alare, T. and Odunitan, T. (2024) ‘Neurological and Molecular Basis of Diabetic Neuropathy’, International Journal of Recent Innovations in Medicine and Clinical Research, 2(4), pp. 75–81. https://doi.org/10.18231/j.ijrimcr.2020.018.
Argoff, C.E. (2022) ‘Reader Response: Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee’, Neurology, 99(21), pp. 966–967. https://doi.org/10.1212/WNL.0000000000201549.
Atmaca, A. et al. (2024) ‘Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach’, Frontiers in Endocrinology, 15. https://doi.org/10.3389/fendo.2024.1380929.
Basu, P., Prasoon, P. and Susuki, K. (2025) ‘Editorial: Understanding and managing diabetic neuropathy: current perspectives and future directions’, Frontiers in Neuroscience, 19. https://doi.org/10.3389/fnins.2025.1582123.
Bodman, M.A., Dreyer, M.A. and Varacallo, M.A. (2024) ‘Diabetic Peripheral Neuropathy’, The Diabetes Textbook: Clinical Principles, Patient Management and Public Health Issues, Second Edition, pp. 923–937. https://doi.org/10.1007/978-3-031-25519-9_56.
Bönhof, G.J. et al. (2019) ‘Emerging Biomarkers, Tools, and Treatments for Diabetic Polyneuropathy’, Endocrine Reviews, 40(1), pp. 153–192. https://doi.org/10.1210/er.2018-00107.
Dillon, B.R., Ang, L. and Pop-Busui, R. (2024) ‘Spectrum of Diabetic Neuropathy: New Insights in Diagnosis and Treatment’, Annual Review of Medicine, 75(1), pp. 293–306. https://doi.org/10.1146/annurev-med-043021-033114.
Harati, Y. (2007) ‘Diabetic Neuropathies: Unanswered Questions’, Neurologic Clinics, 25(1), pp. 303–317. https://doi.org/10.1016/j.ncl.2007.01.002.
Huizinga, M.M. and Peltier, A. (2007) ‘Painful Diabetic Neuropathy: A Management-Centered Review’, Clinical Diabetes, 25(1), pp. 6–15. https://doi.org/10.2337/diaclin.25.1.6.
Kang, Q. et al. (2022) ‘Advanced glycation end products in diabetic retinopathy and phytochemical therapy’, Frontiers in Nutrition, 9, p. 1037186. https://doi.org/10.3389/FNUT.2022.1037186/BIBTEX.
Kang, Y. et al. (2025) ‘Comparative efficacy of moxibustion as an add-on treatment with different durations for diabetic peripheral neuropathy: study protocol for a randomized controlled trial’. https://doi.org/10.3389/fneur.2025.1609674.
Khan, S. et al. (2025) ‘Diabetic Peripheral Neuropathy: Navigating Controversies and Pioneering Advances’, Advancements in Life Sciences, 12(1), pp. 1–12. https://doi.org/10.62940/ALS.V12I1.3627.
Lee, J.-E. and Won, J.C. (2025) ‘Clinical Phenotypes of Diabetic Peripheral Neuropathy: Implications for Phenotypic-Based Therapeutics Strategies’, Diabetes & Metabolism Journal, 49(4), pp. 542–564. https://doi.org/10.4093/dmj.2025.0299.
Mallick-Searle, T. and Adler, J.A. (2024) ‘Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options.’, Journal of pain research, 17(2), pp. 1005–1028. https://doi.org/10.2147/JPR.S442595.
Pantazopoulos, D. et al. (2025) ‘The Trigeminal Nerve in Diabetes Mellitus: A Brief Narrative Review’, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology and German Diabetes Association, 133(6). https://doi.org/10.1055/A-2552-8692.
Price, R. et al. (2022) ‘Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary’, Neurology, 98(1), pp. 31–43. https://doi.org/10.1212/WNL.0000000000013038.
Quiroz-Aldave, J. et al. (2023) ‘Diabetic neuropathy: Past, present, and future’, Caspian Journal of Internal Medicine, 14(2), pp. 153–169. https://doi.org/10.22088/cjim.14.2.153.
Røikjer, J. et al. (2024) ‘Diabetic Peripheral Neuropathy: Emerging Treatments of Neuropathic Pain and Novel Diagnostic Methods.’, Journal of diabetes science and technology, p. 19322968241279550. https://doi.org/10.1177/19322968241279553.
Santosh, K.N. and Janadrdhan, M.S. (2024) ‘Diabetic Neuropathy - A Review’, World Journal of Pharmaceutical and Medical Research, 10(9). Retrieved from: https://www.wjpmr.com/download/article/126082024/1725440296.pdf.
Shinoda, M. et al. (2021) ‘Orofacial Neuropathic Pain-Basic Research and Their Clinical Relevancies’, Frontiers in Molecular Neuroscience, 14, p. 691396. https://doi.org/10.3389/FNMOL.2021.691396.
Shivam, Gupta, A.K. and Kumar, S. (2024) ‘Current Concepts in the Molecular Mechanisms and Management of Diabetic Neuropathy by Pharmacotherapeutics and Natural Compounds’, Central Nervous System Agents in Medicinal Chemistry, 24(3), pp. 264–280. Available at:. https://doi.org/10.2174/0118715249278438240325072758
Sima, A.A.F. and Kamiya, H. (2006) ‘Diabetic Neuropathy Differs in Type 1 and Type 2 Diabetes’, Annals of the New York Academy of Sciences, 1084(1), pp. 235–249. https://doi.org/10.1196/annals.1372.004.
Smith, S. et al. (2022) ‘Prevention and Management Strategies for Diabetic Neuropathy’, Life, 12(8), p. 1185. https://doi.org/10.3390/life12081185
Veerapaneni, K.D. et al. (2024) ‘Trigeminal Neuropathy’, in StatPearls. StatPearls Publishing. https://www.ncbi.nlm.nih.gov/books/NBK556126/
Yang, Y. et al. (2025) ‘Diabetic neuropathy: cutting-edge research and future directions’, Signal Transduction and Targeted Therapy, 10(1), p. 132. https://doi.org/10.1038/s41392-025-02175-1.
Zhou, T. et al. (2022) ‘Diabetic Corneal Neuropathy: Pathogenic Mechanisms and Therapeutic Strategies’, Frontiers in Pharmacology, 13(February), pp. 1–17. https://doi.org/10.3389/fphar.2022.816062.
Zhu, J. et al. (2024) ‘Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment’, Frontiers in Endocrinology, 14. https://doi.org/10.3389/fendo.2023.1265372.
License
Copyright (c) 2025 Susanna Halim, David Rajagukguk
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with Journal of Science and Science Education, agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Attribution 4.0 International (CC BY 4.0). This license allows authors to use all articles, data sets, graphics and appendices in data mining applications, search engines, web sites, blogs, and other platforms by providing an appropriate reference. The journal allows the author(s) to hold the copyright without restrictions and will retain publishing rights without restrictions.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in Journal of Science and Science Education.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
